Drug
lenalidomide
Marketed as REVLIMID.
Generic name
lenalidomide
Brand names
REVLIMID
First FDA approval
2005-12-27
Patient assistance program
Revlimid PSP
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| NDA021880 | REVLIMID | 2005-12-27 | BRISTOL MYERS SQUIBB |
Manufacturers
BRISTOL MYERS SQUIBB
Common denial patterns
- REMS program requirement
- Specialty pharmacy restriction
- Quantity limit
Specific notes
Brand: Revlimid. REMS-restricted distribution.
Manufacturer patient assistance
Revlimid PSP: https://www.revlimid.com
Frequently asked questions
Why does insurance commonly deny lenalidomide?
REMS program requirement; Specialty pharmacy restriction; Quantity limit.
When was lenalidomide FDA approved?
Earliest FDA approval on record: 2005-12-27.
What brand names are sold as lenalidomide?
REVLIMID.
Is there a patient assistance program for lenalidomide?
Yes — Revlimid PSP at https://www.revlimid.com.
What's specific to lenalidomide?
Brand: Revlimid. REMS-restricted distribution.
Sources
Appeal a lenalidomide denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com